In the present study, however, piracetam markedly inhibited Bax and c-Jun protein expression in hippocampi of rats with cerebral ischemia/reperfusion, and significantly increased Bcl-2, while huperzine A only had a marked effect in terms of decreasing Bax levels. The gene discussed is BCL2; the disease is brain ischemia.